Literature DB >> 1663780

The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2.

R C Burnett1, J C David, A M Harden, M M Le Beau, J D Rowley, M O Diaz.   

Abstract

HSB-2 is a cell line derived from a patient who had T-cell acute lymphoblastic leukemia (T-cell ALL) with a t(1;7)(p34;q34). We used a genomic probe from the T-cell receptor beta (TCR beta) locus (7q34) to identify DNA rearrangements in HSB-2. Two rearranged BglII DNA fragments were cloned, and one of these clones was shown to contain the translocation breakpoint on the derivative chromosome I [der(I)]. We used a probe derived from this clone to isolate an unrearranged phage clone encompassing the breakpoint at Ip34. The restriction map of this clone was compared to the published maps of known protooncogenes located at Ip32-34. By restriction mapping, Southern blot analysis, and DNA sequencing we showed that the translocation breakpoint on chromosome I is located within the first intron of the LCK gene. The LCK gene codes for p56lck, a member of the SRC family of cytoplasmic tyrosine protein kinases. There are two classes of LCK transcripts (type I and type II), each expressed from a distinct promoter, and each having a unique 5' untranslated region (UTR); the protein coding regions of the two classes are identical. The breakpoint in the t(1;7) separates the two LCK promoters and juxtaposes the constant region of the TCR beta locus with the proximal promoter and with the protein-coding region of the LCK gene on the der(I) chromosome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663780     DOI: 10.1002/gcc.2870030608

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping.

Authors:  Michael R Rossi; Jeff Laduca; John K Cowell; Bejai I S Srivastava; Seiichi Matsui
Journal:  Leuk Res       Date:  2007-07-20       Impact factor: 3.156

2.  Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.

Authors:  S Fears; C Mathieu; N Zeleznik-Le; S Huang; J D Rowley; G Nucifora
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Src kinase signaling in leukaemia.

Authors:  Shaoguang Li
Journal:  Int J Biochem Cell Biol       Date:  2007-02-09       Impact factor: 5.085

5.  Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells.

Authors:  K R Solomon; M A Mallory; R W Finberg
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.

Authors:  Jesús Duque-Afonso; Chiou-Hong Lin; Kyuho Han; Michael C Wei; Jue Feng; Jason H Kurzer; Corina Schneidawind; Stephen Hon-Kit Wong; Michael C Bassik; Michael L Cleary
Journal:  Cancer Res       Date:  2016-10-07       Impact factor: 12.701

7.  Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia.

Authors:  D D Wright; B M Sefton; M P Kamps
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.

Authors:  Shahrooz Vahedi; Fu-Yu Chueh; Sujoy Dutta; Bala Chandran; Chao-Lan Yu
Journal:  Oncol Rep       Date:  2015-05-19       Impact factor: 3.906

9.  Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.

Authors:  Shahrooz Vahedi; Fu-Yu Chueh; Bala Chandran; Chao-Lan Yu
Journal:  BMC Cancer       Date:  2015-07-26       Impact factor: 4.430

10.  Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation.

Authors:  Jennifer A Rohrs; Pin Wang; Stacey D Finley
Journal:  Cell Mol Bioeng       Date:  2016-04-26       Impact factor: 2.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.